ClinicalTrials.Veeva

Menu

Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy

M

Maria Sklodowska-Curie National Research Institute of Oncology

Status

Completed

Conditions

Non-Small Cell Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The patients from 12 centers were included into the study. pN2 patients received PORT, pN1 patients did not. PORT was 3D-planned and consisted in 54-56 Gy in 27-28 fractions. One month after surgery, all patients completed EORTC QLQ C-30 questionnaires and had pulmonary function tests (PFT); cardiopulmonary symptoms were assessed by modified LENT-SOM score. Two years after, all patients free of disease repeated the same examinations. Changes in QLQ, LENT-SOM score and the results of PFT were compared for patients receiving and not PORT.

Enrollment

293 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • complete resection by lobectomy, bi-lobectomy or pneumonectomy of NSCLC,
  • pN1 or pN2 disease,
  • signed informed consent for participation in the study,
  • Karnofsky Performance Status (KPS) higher than 70%.

Exclusion criteria

  • presence of distant metastases,
  • N2 diagnosed before surgery in imaging and/or mediastinoscopy,
  • previous radiotherapy to the chest,
  • no or inadequate mediastinal nodal dissection ,
  • FEV1 after surgery lower than 1.0 liter,
  • any active infectious process (including fistula formation) in the chest

Trial design

293 participants in 2 patient groups

Stage II patients post surgery
Description:
Stage II patients treated with surgery alone
Stage III patients post surgery
Description:
Stage III patients treated with surgery and PORT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems